ARCA biopharma, Inc.

ARCA biopharma, Inc.

ARCA biopharma, Inc.

Date Founded




Type of Company


Employees (Worldwide)



Medical Support Services

Company Description

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

Contact Data
Trying to get in touch with decision makers at ARCA biopharma, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees


Chief Financial Officer & Senior Vice President

Vice President of Finance Acting Chief Financial Officer & Chief Accounting Officer

Chief Operating Officer

Vice Chairman of the Board & Director

Benefit Plan Administrator


Regulatory Affairs

Investor Relations & Media Contact

Board of Directors

Former Chief Executive Officer, Director at Array BioPharma Inc.

Co-Founder, Director at Miragen Therapeutics, Inc.

Managing Partner at Amzak Capital Management LLC

Founder at Critical Path Institute

Paths to ARCA biopharma, Inc.
Potential Connections via
Relationship Science
ARCA biopharma, Inc.
Recent Transactions
Details Hidden

ARCA biopharma, Inc. purchases Cardiovascular Pharmaceuticals & Engineering Consultants LLC from Aeolus Pharmaceuticals Inc.

Details Hidden

ARCA biopharma, Inc. raised money in a private placement transaction

Details Hidden

ARCA biopharma, Inc. raised money in a private placement transaction

Transaction Advisors
Selling Group Member

Advised onARCA biopharma, Inc. issued USD Common Stock

Selling Group Member

Advised onARCA biopharma, Inc. issued USD Common Stock

Investment Advisor

Advised onARCA biopharma, Inc. raised money in a private placement transaction

Investment Advisor

Advised onARCA biopharma, Inc. raised money in a private placement transaction

Administrator-Syndicate/Investment Banking

Advised onARCA biopharma, Inc. raised money in a private placement transaction

Advisors & Consultants

Chief Financial Officer at Black Bear Energy, Inc.

Key Stats and Financials As of 2019
Market Capitalization
Total Enterprise Value
Earnings Per Share
Net Profit
Total Debt
Total Equity
TEVNet Income
Debt TEV
Non-Profit Donations & Grants
Patheon, Inc. Pharmaceuticals | Mississauga, Canada

Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada.

Novasep Holding SAS Other Business & Consulting Services | Lyon, France

Novasep Holding SAS operates as a holding company with interest in providing manufacturing solutions for the life science industries. It services encompass custom and contract manufacturing for active pharmaceutical ingredients and case studies. The firm has two business divisions Novasep Process and Novasep Synthesis. Its products and services include agrochemicals fine chemicals, food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France.

Endo International Plc Wholesale: Medical Supplies & Pharmaceuticals | Dublin, Ireland

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: U.S. Branded-Specialty & Established Pharmaceuticals, U.S. Branded-Sterile Injectables, U.S. Generic Pharmaceuticals and International Pharmaceuticals. The U.S. Branded-Specialty & Established Pharmaceuticals segment offers prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain and orthopedics. The U.S. Branded-Sterile Injectables segment consists primarily of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. The U.S. Generic Pharmaceuticals segment consists of a differentiated product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays and includes products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health and cardiovascular disease markets, among others. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. The company was founded in 1997 and is headquartered Dublin, Ireland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ARCA biopharma, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ARCA biopharma, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and ARCA biopharma, Inc..